Fig. 4From: Femoral bone mineral density and bone mineral content in bromocriptine-treated pregnant and lactating ratsBMD and BMC of proximal and distal femoral metaphyses (Met.) and femoral diaphyses in a,b 14-day pregnant rats (P14), and c,d 21-day pregnant rats (P21) treated with bromocriptine (Bromo). ***P < 0.001 compared with vehicle-treated age-matched control group. Numbers in parentheses represent the number of animals in each groupBack to article page